drugset / Trial / NCT06116916
Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with DME.
Timeline
- Start
- 2024-01-09
- Primary completion
- 2026-08-31
- Completion
- 2026-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KHK4951 | Unknown | — | Other |
| Background | Aflibercept | Protein / enzyme biologic | — | Intravitreal |